Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies
ClinicalTrials.gov study NCT03076437. IPD Sharing: NO. Countries: 1. Publications: 0.
The Clinical Research of Anti-CD20 CAR-T Cells in Patients With Refractory or Relapsed B Lymphocyte Lymphoma
ClinicalTrials.gov study NCT03576807. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01647971. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant
ClinicalTrials.gov study NCT00434629. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Relapsed Grade 3b Follicular Lymphoma
ClinicalTrials.gov study NCT04156828. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
ClinicalTrials.gov study NCT07221500. IPD Sharing: NO. Countries: 4. Publications: 0.
A Phase I Clinical Trial of SyB L-0501 in Combination With Rituximab to Patients With Aggressive B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00794638. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
ClinicalTrials.gov study NCT06625190. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05991388. IPD Sharing: NO. Countries: 7. Publications: 0.
TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT05507541. IPD Sharing: Not stated. Countries: 1. Publications: 0.
18F-FDG PET Scan and MRI Diffusion.Evaluation of the Early Therapeutic Response of Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT03121456. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of LP002 for the Treatment of Patients With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma
ClinicalTrials.gov study NCT04600947. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
ClinicalTrials.gov study NCT05480449. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND)
ClinicalTrials.gov study NCT05429268. IPD Sharing: NO. Countries: 14. Publications: 0.
Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor Cells
ClinicalTrials.gov study NCT00458679. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19 CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT03854994. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Azacytidine, Bendamustine, Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT04897477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT03373019. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of bbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT05169489. IPD Sharing: YES. Countries: 1. Publications: 0.
A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)
ClinicalTrials.gov study NCT06446128. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.